Faeth Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +65.9% | +186.3% | +227.8% | +96.6% | +0.3% | -2.1% | -89.5% | |
| – | – | – | +279.2% | +2.7% | -23.4% | -29.6% | -59.4% | |
| – | +132.8% | -111.4% | – | +761.5% | -529.6% | – | – | |
| – | +71.0% | +2,175.5% | +68.0% | -84.2% | -43.9% | -18.9% | -89.0% | |
| – | +71.0% | +2,547.2% | +10,100.9% | – | -23.1% | -41.6% | -11.9% | |
| – | – | – | – | – | – | -100.0% | – | |
| – | – | – | – | – | +21.0% | +6.6% | -20.1% | |
| – | +996.3% | +331.2% | +362.4% | -100.2% | +3,793.0% | -93.0% | -18.0% | |
| – | – | – | -157.7% | – | -145.0% | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.